An Israeli SME, which specialises in high quality production of generic products, offers a diversified range of finished pharmaceutical products. The products may be used in regular medical treatment. Advantages over those on the market include ability to adapt a product to customer needs, high quality of the final products. Possible types of cooperation are commercial agency agreement & distribution services agreement.
An Israeli company that offers a range of generic products providing for high quality treatment along with cost-effective approach. The developed range of products treats various medical conditions in many therapeutic segments such as respiratory, CNS, orthopaedic, skin diseases etc. Some of the topical products may offer innovative approach developed for topical applications.
The company has been operating in Israeli market since the 1960's producing and marketing its branded generics. For many years the company has also been acting as a contract manufacturer of other Israeli companies. Looking to work with distributors and also for agreements providing assistance in expanding global presence of product and selling and promoting the company's products in new markets while also expanding their brand.
- Specific area of activity of the partner: The type of Partner Sought - business organisations.
Professional activity – healthcare professional, pharmaceutical distribution, marketing, representatives, agencies, manufacturers in the field of pharmaceutics / healthcare.
The tasks to be performed by the partner sought - registering the product in the relevant health authorities, distribution, marketing promotion of products.
The company is seeking to expand its distribution network with agreements in order to create global strategic alliances, expand their brand, and distribute their products in new markets.
Innovative topical formulations of drugs and medicated cosmetics for
high-quality generic products enable:
1. Effective and user-friendly customizing of final products.
2. High quality of the production standards mutually recognized by EU as well as the Prior Informed Content (PIC) convention.
3. Advanced specially developed equipment and long experience allow wide range of pharmaceutical forms (both oral and topical – liquids, semisolids, solids) of final products
Already on the market
Clasificado como: Manufactura Industrial \ Ciencias de la vida \ Industria
Seleccione una de las siguientes opciones para interesarse por esta oportunidad: